Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
Sign Up to like & getrecommendations! Published in 2021 at "Pain physician"
DOI: 10.36076/ppj.2021.24.153-163
Abstract: BACKGROUND Although conventional pain relief therapeutics have centered around mu-opioid agonists, these drugs are limited by adverse side effects, including respiratory depression and addiction potential. The ongoing opioid epidemic has galvanized research into novel analgesic… read more here.
Keywords: analgesic therapies; analgesic targets; novel analgesic; development ... See more keywords